IDH2 and central nervous system cancer: We studied cytosine methylation in the CpG context with a minimal coverage of 10 reads per cytosine, in the IDH-MUT, G2/G3 IDH-WT and G4 IDH-WT glioma methylomes, deposited in glioma Atlas [27].